SEC Form D · filed November 17, 2021
NovaBay Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Paul E. Freiman · EMERYVILLE, CADirectorAndrew M. Jones · EMERYVILLE, CAExecXinzhou (Paul) E. Li · EMERYVILLE, CADirectorJustin M. Hall · EMERYVILLE, CAExec · DirectorJeffrey M. Kunin · KANSAS CITY, MOExecYenyou (Jeff) E. Zheng · EMERYVILLE, CADirectorAudrey M. Kunin · KANSAS CITY, MOExecSwan E. Sit · EMERYVILLE, CADirectorMijia (Bob) E. Wu · EMERYVILLE, CADirectorJp A. Paquin · New York, NYDirectorSeth M. Tjaden · Huxley, IAExecSean Stiefel · Redondo Beach, CAExecWilliam Burns · McKinney, TXExec · DirectorCato Partners GP, LLC · New York, NYDirectorSamuel Schreiber · Chilmark, MADirectorJill M. Smith · Huxley, IAExecCato Partners Management, LLC · New York, NYDirectorBrook Katzen · Chilmark, MADirectorDavid Irwin · Bellevue, WADirectorSteven M. Diedrich · Waco, TXDirectorJerry L. Whitmire · Tempe, AZDirectorvan Biema Value Partners, LLC · New York, NYDirectorvan Biema & Company, LLC · New York, NYExecJeff Siegel · Huntsville, UTExec · DirectorStephen Dalby · Lehi, UTDirectorAnupkumar M. Shetty, M.D · Dallas, TXExecJoris M. Schuller, Jr., M.D · Dallas, TXExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗